Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanlan Chen

Showing results (201-210 of 202) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 202 results.
BMC Infectious Diseases|January 9, 2022
Optimal encephalitis/meningitis roadmap via precise diagnosis and treatment (IMPROVE): a study protocol for a randomized controlled trialYi Zhang, Haocheng Zhang, Bo Deng, et al.
Alzheimer'S Research & Therapy|March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementiaShifu Xiao, Piu Chan, Tao Wang, et al.
Pageof 21

Showing results (201-210 of 202) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 202 results.
BMC Infectious Diseases|January 9, 2022
Optimal encephalitis/meningitis roadmap via precise diagnosis and treatment (IMPROVE): a study protocol for a randomized controlled trialYi Zhang, Haocheng Zhang, Bo Deng, et al.
Alzheimer'S Research & Therapy|March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementiaShifu Xiao, Piu Chan, Tao Wang, et al.
Pageof 21